OthoPediatrics is a bioscience company dedicated to improving the resources available for treating children's orthopedic conditions through inventing, designing, and distributing innovative and anatomically appropriate implants, unique instrumentation and biologics for pediatric and small stature patients. The QCR by OrthoPediatrics is a game changing, disruptive technology. With an operating sound level just above a whisper and no vibration, the OrthoPediatrics QCR completely removes anxiety due to the noise and vibration.
Type
Public
HQ
Warsaw, US
Founded
2006
Size (employees)
150 (est)+50%
OrthoPediatrics was founded in 2006 and is headquartered in Warsaw, US
Report incorrect company information

Key People/Management at OrthoPediatrics

Mark Throdahl

Mark Throdahl

President & CEO

OrthoPediatrics Office Locations

OrthoPediatrics has an office in Warsaw
Warsaw, US (HQ)
2850 Frontier Dr
Show all (1)
Report incorrect company information

OrthoPediatrics Financials and Metrics

OrthoPediatrics Revenue

Embed Graph
OrthoPediatrics's revenue was reported to be $37.30 m in FY, 2016 which is a 20.3% increase from the previous period.
USD

Revenue (Q3, 2017)

12.4 m

Gross profit (Q3, 2017)

9.5 m

Gross profit margin (Q3, 2017), %

76.7%

Net income (Q3, 2017)

(1.5 m)

EBIT (Q3, 2017)

(756 k)

Market capitalization (14-Aug-2018)

365.7 m

Closing stock price (14-Aug-2018)

28.6

Cash (30-Sep-2017)

2.2 m

EV

391 m
OrthoPediatrics's current market capitalization is $365.7 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

23.7 m31 m37.3 m

Revenue growth, %

31%20%

Cost of goods sold

7.1 m9.4 m10.9 m

Gross profit

16.6 m21.6 m26.4 m
Quarterly
USDQ3, 2016Q3, 2017

Revenue

10.1 m12.4 m

Cost of goods sold

3 m2.9 m

Gross profit

7.2 m9.5 m

Gross profit Margin, %

71%77%
Annual
USDFY, 2015FY, 2016

Cash

3.9 m1.6 m

Accounts Receivable

3.8 m4.1 m

Prepaid Expenses

222 k233 k

Inventories

11.7 m14 m
Quarterly
USDQ2, 2017Q3, 2017

Cash

2.3 m2.2 m

Accounts Receivable

6.5 m5.7 m

Prepaid Expenses

960 k615 k

Inventories

18.1 m19 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

(9.5 m)(7.9 m)(6.6 m)

Depreciation and Amortization

1.6 m1.9 m1.9 m

Inventories

(360 k)1.6 m(1 m)

Accounts Payable

(445 k)1.4 m1.5 m
Quarterly
USDQ2, 2016Q3, 2016Q2, 2017Q3, 2017

Net Income

(2.1 m)(2.9 m)(2.6 m)(4.1 m)

Depreciation and Amortization

903 k1.4 m1.1 m1.7 m

Inventories

(2.8 m)(3.6 m)

Accounts Payable

1.9 m1.8 m2.6 m1.6 m
USDY, 2017

EV/EBIT

-517.2 x

EV/CFO

-100.4 x

Debt/Equity

-0.4 x

Debt/Assets

0.7 x

Financial Leverage

-0.6 x
Show all financial metrics

OrthoPediatrics Operating Metrics

OrthoPediatrics's Patients was reported to be 16 k in Y, 2016.
Y, 2016Jun, 2017Nov, 2017

Hospitals

300

Patients

16 k

Stock Keeping Units

2.60 k2.70 k

Patents Issued

21 21
Show all operating metrics

OrthoPediatrics Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
OrthoPediatrics AUS PTY LTD
OrthoPediatrics EU Limited
OrthoPediatrics NZ Limited
OrthoPediatrics United States Distribution Corp.
Report incorrect company information

OrthoPediatrics Online and Social Media Presence

Embed Graph
Report incorrect company information

OrthoPediatrics News and Updates

OrthoPediatrics Announces Expanded Indication for FIREFLY® Pedicle Screw Navigation Guides

WARSAW, Ind., July 31, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that FIREFLY® Pedicle Screw Navigation Guides (“FIREFLY”) received additional FDA 510(k) clearance for an expan…

Pediatric Orthopedic Implants 2018 North America Market Key Players – Arthrex, Johnson & Johnson, K2M, OrthoPediatrics – Analysis and Forecast to 2022

WiseGuyRerports.com Presents “Pediatric Orthopedic Implants Market in North America 2018-2022” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

OrthoPediatrics Company Life and Culture

Report incorrect company information